Advertisement
Singapore markets closed
  • Straits Times Index

    3,343.35
    +11.65 (+0.35%)
     
  • S&P 500

    5,477.00
    -0.90 (-0.02%)
     
  • Dow

    39,179.22
    +51.42 (+0.13%)
     
  • Nasdaq

    17,820.20
    +15.04 (+0.08%)
     
  • Bitcoin USD

    61,741.66
    +79.09 (+0.13%)
     
  • CMC Crypto 200

    1,287.82
    +21.68 (+1.71%)
     
  • FTSE 100

    8,206.38
    -18.95 (-0.23%)
     
  • Gold

    2,340.40
    +27.20 (+1.18%)
     
  • Crude Oil

    81.73
    +0.83 (+1.03%)
     
  • 10-Yr Bond

    4.2830
    -0.0330 (-0.76%)
     
  • Nikkei

    39,341.54
    -325.53 (-0.82%)
     
  • Hang Seng

    17,716.47
    -373.46 (-2.06%)
     
  • FTSE Bursa Malaysia

    1,584.94
    -6.01 (-0.38%)
     
  • Jakarta Composite Index

    6,967.95
    +62.31 (+0.90%)
     
  • PSE Index

    6,390.58
    +77.47 (+1.23%)
     

Obesity-Drug Developers Look at What’s Next for a $100 Billion Market

Obesity-Drug Developers Look at What’s Next for a $100 Billion Market

Oppenheimer analyst Jay Olson spent several days last week listening as companies such as Eli Lilly discussed how to improve on blockbusters like Zepbound and Novo Nordisk’s Wegovy.